Global Rates of Alzheimer's Disease Soar

Financial advisers ponder meaning of 'competence'

(NEWSER) - The first sign of Arthur Packel's Alzheimer's was the call from the homeowner's association asking for unpaid fees. As his mind began its long slide, it turns out, the first thing he did was simply stop paying bills. When his wife tried to pick up the slack, she found much of their money gone. And despite a forensic accountant's efforts, “It just disappeared,” Renee Packel tells the New York Times . More»

China, India helped draft leaked agreement they railed against

(NEWSER) - The “Danish text”—the leaked climate change agreement that infuriated developing nations in Copenhagen and sparked accusations of bullying by rich countries—was actually drafted by a group that included China, India, and Brazil, among other countries. They had “input into the process and product” of the agreement, which seeks to impose stricter limits on developing nations’ emissions, an insider tells the Los Angeles Times . More»

Lowering it won't necessarily help, studies suggest

(NEWSER) - High cholesterol in middle age may increase a person’s future risk of Alzheimer’s disease, NPR reports. “Our study shows that even moderately high cholesterol levels in your 40s puts people at greater risk for Alzheimer's disease and vascular dementia in later life,” says one researcher, who worked on a study of nearly 10,000 people that began in the 1960s. More»

(NEWSER) - The Alzheimer’s patient had forgotten nearly everything, including his own name, but the sound of Frank Sinatra moved him to grab his wife and dance. The phenomenon demonstrates how deep-seated music is in the human brain, Sara Davidson writes for the New York Times’ New Old Age blog. “If someone sang to you as a baby, before you even knew words, you’ll respond to music after words are gone.” More»

Treatment removed damaging protein from blood, brains of patients

(NEWSER) - British researchers believe a new drug has the potential to stop Alzheimer's disease in its tracks, reports the BBC. Testing found that the drug, called CPHPC, removed a protein thought to play a key role in Alzheimer's from the blood and, unexpectedly, the brain, in five patients treated for 3 months. The research—still in its early stages—was hailed by experts as grounds for “cautious optimism." More»